Their work, published in Advanced Science ("Targeted DNA Nanomachine Enables Specific miRNA-Responsive Singlet Oxygen Amplification for Precise Cutaneous Squamous Cancer Therapy"), introduces a new ...

A new University of Cincinnati Cancer Center study has identified a particular strand of microRNA as a promising new target ...

Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have validated a test that can accurately predict which ...

A test to identify higher risk of developing urinary side effects after radiation in patients with prostate cancer was ...

In recent years, chemotherapy-induced cardiovascular disease has emerged as a significant cause of mortality among cancer ...

In April 2021, they showed that their device can also detect urinary microRNA profiles ... to date is in early cancer and minimal residual disease detection after treatment, further research ...

The firm is developing a kitted version of the four-biomarker combination test, and it plans to commercialize them in the EU and US markets.

Combined serum CA19-9 and miR-27a-3p in peripheral blood mononuclear cells to diagnose pancreatic cancer. Cancer Prev ... The evaluated study examined the miRNA profiles in peripheral blood ...

Through the mouse model, the researchers found that a cluster of miRNAs, labeled miRNA 290-295 in mice, were exclusively expressed and secreted by undifferentiated testicular cancer cells.